Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism

References

• Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361(9356):512–22. doi:10.1016/S0140-6736(03)12489-0.
   PubMed Web of Science ®Google Scholar
• de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–1032. doi:10.1136/gutjnl-2021-326789.
   PubMed Web of Science ®Google Scholar
• Eriksson H, Gustafsson JÅ, Sjövall J Steroids in germfree and conventional rats. European Journal of Biochemistry 1969;9:286–290.
   PubMedGoogle Scholar
• Chen KL, Madak-Erdogan Z. Estrogen and microbiota crosstalk: Should we pay attention? Trends Endocrinol Metab. 2016;27(11):752–755. doi:10.1016/j.tem.2016.08.001.
   PubMed Web of Science ®Google Scholar
• Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host & Microbe. 2011;10(4):324–335. doi:10.1016/j.chom.2011.10.003.
   PubMed Web of Science ®Google Scholar
• Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, Redinbo MR. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294(49):18586–18599. doi:10.1074/jbc.RA119.010950.
   PubMed Web of Science ®Google Scholar
• Masamune H. Biochemical studies on carbohydrates: IV. On an enzyme which catalyses the hydrolysis of biosynthetic osides of glucuronic acid. J Biochem. 1934;19(2):353–375. doi:10.1093/oxfordjournals.jbchem.a125337.
   Google Scholar
• Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas. 2017;103:45–53. doi:10.1016/j.maturitas.2017.06.025.
   PubMed Web of Science ®Google Scholar
• Sui Y, Wu J, Chen J. The role of gut microbial β-glucuronidase in estrogen reactivation and breast cancer. Front Cell Dev Biol. 2021;9:631552. doi:10.3389/fcell.2021.631552.
   PubMed Web of Science ®Google Scholar
• Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of Estrogen Receptors Alpha (ER-alpha) and Beta (ER-alpha) mRNA in the midgestational human fetus. J Clin Endocrinol Metab. 1997;82(10):3509–3512. doi:10.1210/jc.82.10.3509.
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Slaunwhite WR Jr. Studies on phenolic steroids in human subjects. II. The metabolic fate and hepato-biliary-enteric circulation of C14-estrone and C14-estradiol in women. J Clin Invest. 1957;36(8):1266–1278. doi:10.1172/JCI103524.
   PubMed Web of Science ®Google Scholar
• Sandberg AA, Slaunwhite WR Jr. Studies on phenolic steroids in human subjects. vii. metabolic fate of estriol and its glucuronide. J Clin Invest. 1965;44(4):694–702. doi:10.1172/JCI105181.
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Järvenpää P. Assay of estrogens in human feces. J Steroid Biochem. 1982;17(6):639–645. doi:10.1016/0022-4731(82)90565-9.
   PubMedGoogle Scholar
• Fishman WH, Fishman LW. THE ELEVATION of UTERINE β-GLUCURONIDASE ACTIVITY by ESTROGENIC HORMONES. J Biol Chem. 1944;152(2):487–488. doi:10.1016/S0021-9258(18)72081-4.
   Google Scholar
• Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B. The carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res. 2014;42(D1):D490–5. doi:10.1093/nar/gkt1178.
   PubMed Web of Science ®Google Scholar
• An J, Kwon H, Lim W, Moon B-I. Staphylococcus aureus-derived extracellular vesicles enhance the efficacy of endocrine therapy in breast cancer cells. J Clin Med. 2022;11(7):11. doi:10.3390/jcm11072030.
   Web of Science ®Google Scholar
• Gao S, Sun R, Singh R, Yu so S, Chan CTY, Savidge T, Hu M. The role of gut microbial β-glucuronidase in drug disposition and development. Drug Discov Today. 2022;27(10):103316. doi:10.1016/j.drudis.2022.07.001.
   PubMed Web of Science ®Google Scholar
• Sui Y, Wu J, Chen J. The role of gut microbial β-glucuronidase in estrogen reactivation and breast cancer. Front In Cell And Dev Biol. 2021;9. doi:10.3389/fcell.2021.631552.
   Web of Science ®Google Scholar
• Wu Q, Zhou QH, Li W, Ren T-B, Zhang X-B, Yuan L. Evolving an ultra-sensitive near-infrared β-galactosidase fluorescent probe for breast cancer imaging and surgical resection navigation. ACS Sens. 2022;7(12):3829–3837. doi:10.1021/acssensors.2c01752.
   PubMed Web of Science ®Google Scholar
• Kwa M, Plottel CS, Blaser MJ, Adams S. The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst. 2016;108(8). doi:10.1093/jnci/djw029.
   PubMedGoogle Scholar
• Pollet RM, D’Agostino EH, Walton WG, Xu Y, Little MS, Biernat KA, Pellock SJ, Patterson LM, Creekmore BC, Isenberg HN, et al. An atlas of β-glucuronidases in the human intestinal microbiome. Structure. 2017;25(7):967–977.e5. doi:10.1016/j.str.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Creekmore BC, Gray JH, Walton WG, Biernat KA, Little MS, Xu Y, Liu J, Gharaibeh RZ, Redinbo MR. Mouse gut microbiome-encoded β-glucuronidases identified using metagenome analysis guided by protein structure. mSystems. 2019;4(4):4. doi:10.1128/mSystems.00452-19.
   Web of Science ®Google Scholar
• Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh L-A, Mani S, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330(6005):831–835. doi:10.1126/science.1191175.
   PubMed Web of Science ®Google Scholar
• Candeliere F, Raimondi S, Ranieri R, Musmeci E, Zambon A, Amaretti A, Rossi M. β-glucuronidase pattern predicted from gut metagenomes indicates potentially diversified pharmacomicrobiomics. Front Microbiol. 2022;13:826994. doi:10.3389/fmicb.2022.826994.
   PubMed Web of Science ®Google Scholar
• Dabek M, McCrae SI, Stevens VJ, Duncan SH, Louis P. Distribution of β-glucosidase and β-glucuronidase activity and of β-glucuronidase gene gus in human colonic bacteria. FEMS Microbiol Ecol. 2008;66(3):487–495. doi:10.1111/j.1574-6941.2008.00520.x.
   PubMed Web of Science ®Google Scholar
• Gloux K, Berteau O, El Oumami H, Béguet F, Leclerc M, Doré J. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome. Proc Natl Acad Sci USA. 2011;108(supplement_1):4539–4546. doi:10.1073/pnas.1000066107.
   PubMedGoogle Scholar
• McIntosh FM, Maison N, Holtrop G, Young P, Stevens VJ, Ince J, Johnstone AM, Lobley GE, Flint HJ, Louis P, et al. Phylogenetic distribution of genes encoding β-glucuronidase activity in human colonic bacteria and the impact of diet on faecal glycosidase activities. Environ Microbiol. 2012;14(8):1876–1887. doi:10.1111/j.1462-2920.2012.02711.x.
   PubMed Web of Science ®Google Scholar
• Carrette O, Favier C, Mizon C, Neut, C., Cortot, A., Colombel, J F., Mizon, J. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn’s disease. Digest Dis Sci. 1995;40(12):2641–2646. doi:10.1007/BF02220454.
   PubMed Web of Science ®Google Scholar
• Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther. 2006;5(10):1265–1269. doi:10.4161/cbt.5.10.3296.
   PubMed Web of Science ®Google Scholar
• Lombardi P, Goldin B, Boutin E, Gorbach SL. Metabolism of androgens and estrogens by human fecal microorganisms. J Steroid Biochem. 1978;9(8):795–801. doi:10.1016/0022-4731(78)90203-0.
   PubMedGoogle Scholar
• Adlercreutz H, Pulkkinen MO, Hämäläinen EK, Korpela JT. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. J Steroid Biochem. 1984;20(1):217–229. doi:10.1016/0022-4731(84)90208-5.
   PubMedGoogle Scholar
• Li D, Sun T, Tong Y, Le J, Yao Q, Tao J, Liu H, Jiao W, Mei Y, Chen J, et al. Gut-microbiome-expressed 3β-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females. Cell Metab. 2023;35(4):685–694.e5. doi:10.1016/j.cmet.2023.02.017.
   PubMed Web of Science ®Google Scholar
• Chan AA, Bashir M, Rivas MN, Duvall K, Sieling PA, Pieber TR, Vaishampayan PA, Love SM, Lee DJ. Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Rep. 2016;6(1):28061. doi:10.1038/srep28061.
   PubMedGoogle Scholar
• Byrd DA, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg‐Lamptey J-N, Yarney J, Wiafe‐Addai B, Wiafe S, Awuah B, et al. Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study. Int J Cancer. 2021;148(11):2712–2723. doi:10.1002/ijc.33473.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qin X, Hu D, Huang J, Guo E, Xiao R, Li W, Sun C, Chen G. Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer. Cell Rep. 2022;41(13):111890. doi:10.1016/j.celrep.2022.111890.
   PubMed Web of Science ®Google Scholar
• Lin C, Zeng Z, Lin Y, Wang P, Cao D, Xie K, Luo Y, Yang H, Yang J, Wang W, et al. Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota. Phytomedicine. 2022;106:154401. doi:10.1016/j.phymed.2022.154401.
   PubMed Web of Science ®Google Scholar
• Zhao SS, Chen L, Yang J, Wu Z-H, Wang X-Y, Zhang Q, Liu W-J, Liu H-X. Altered gut microbial profile accompanied by abnormal fatty acid metabolism activity exacerbates endometrial cancer progression. Microbiol Spectr. 2022;10(6):e0261222. doi:10.1128/spectrum.02612-22.
   PubMed Web of Science ®Google Scholar
• Gressel GM, Usyk M, Frimer M, Kuo DYS, Burk RD. Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers. PLoS One. 2021;16(11):e0259188. doi:10.1371/journal.pone.0259188.
   PubMed Web of Science ®Google Scholar
• Yuan M, Li D, Zhang Z, Sun H, An M, Wang G. Endometriosis induces gut microbiota alterations in mice. Hum Reprod. 2018;33(4):607–616. doi:10.1093/humrep/dex372.
   PubMed Web of Science ®Google Scholar
• Chadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, Kommagani R. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota. Hum Reprod. 2019;34(6):1106–1116. doi:10.1093/humrep/dez041.
   PubMed Web of Science ®Google Scholar
• Peters BA, Lin J, Qi Q, Usyk M, Isasi CR, Mossavar-Rahmani Y, Derby CA, Santoro N, Perreira KM, Daviglus ML, et al. Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the hispanic community health study/study of latinos. mSystems. 2022;7(3):e0027322. doi:10.1128/msystems.00273-22.
   PubMed Web of Science ®Google Scholar
• Chen KLA, Liu X, Zhao YC, Hieronymi K, Rossi G, Auvil LS, Welge M, Bushell C, Smith RL, Carlson KE, et al. Long-term administration of conjugated estrogen and bazedoxifene decreased murine fecal β-glucuronidase activity without impacting overall microbiome community. Sci Rep. 2018;8(1):8166. doi:10.1038/s41598-018-26506-1.
   PubMedGoogle Scholar
• Wu Z, Pfeiffer RM, Byrd DA, Wan Y, Ansong D, Clegg-Lamptey J-N, Wiafe-Addai B, Edusei L, Adjei E, Titiloye N, et al. Associations of circulating estrogens and estrogen metabolites with fecal and oral microbiome in postmenopausal women in the ghana breast health study. Microbiol Spectr. 2023:e0157223. doi:10.1128/spectrum.01572-23
   PubMed Web of Science ®Google Scholar
• Fuhrman BJ, Feigelson HS, Flores R, Gail MH, Xu X, Ravel J, Goedert JJ. Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab. 2014;99(12):4632–4640. doi:10.1210/jc.2014-2222.
   PubMed Web of Science ®Google Scholar
• da Silva TCA, Dos Santos Gonçalves JA, Souza L, Lima AA, Guerra-Sá R. The correlation of the fecal microbiome with the biochemical profile during menopause: a Brazilian cohort study. BMC Womens Health. 2022;22(1):499. doi:10.1186/s12905-022-02063-8.
   PubMed Web of Science ®Google Scholar
• Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10(1):253. doi:10.1186/1479-5876-10-253.
   PubMedGoogle Scholar
• Liu Y, Zhou Y, Mao T, Huang Y, Liang J, Zhu M, Yao P, Zong Y, Lang J, Zhang Y, et al. The relationship between menopausal syndrome and gut microbes. BMC Womens Health. 2022;22(1):437. doi:10.1186/s12905-022-02029-w.
   PubMed Web of Science ®Google Scholar
• Pavlovska OM, Pavlovska KM, Heryak SM, Khmil SV, Khmil MS. Vasomotor menopausal disorders as a possible result of dysfunction of the microbiota-intestine-brain axis. J Med Life. 2022;15(2):234–240. doi:10.25122/jml-2021-0106.
   PubMedGoogle Scholar
• Yang X, Xiao H, Zeng Y, Huang L, Ji K, Deng D, Yang W, Liu L. Tianwang buxin granules influence the intestinal flora in perimenopausal insomnia. Biomed Res Int. 2021;2021:1–9. doi:10.1155/2021/9979511.
   PubMed Web of Science ®Google Scholar
• Ma S, Qin J, Hao Y, Shi Y, Fu L. Structural and functional changes of gut microbiota in ovariectomized rats and their correlations with altered bone mass. Aging (Albany NY). 2020;12(11):10736–10753. doi:10.18632/aging.103290.
   PubMedGoogle Scholar
• Borella F, Carosso AR, Cosma S, Preti M, Collemi G, Cassoni P, Bertero L, Benedetto C. Gut microbiota and gynecological cancers: A summary of pathogenetic mechanisms and future directions. ACS Infect Dis. 2021;7(5):987–1009. doi:10.1021/acsinfecdis.0c00839.
   PubMed Web of Science ®Google Scholar
• Fishman WH. B-Glucuronidase activity of the blood and tissues of obstetrical and surgical patients. Science. 1947;105(2738):646–647. doi:10.1126/science.105.2738.646.
   PubMed Web of Science ®Google Scholar
• Fishman WH, Anlyan AJ. Comparison of the β-glucuronidase activity of normal, tumor, and lymph node tissues of surgical patients. Science. 1947;106(2742):66–67. doi:10.1126/science.106.2742.66.
   PubMed Web of Science ®Google Scholar
• Hill MJ, Goddard P, Williams RE. Gut bacteria and aetiology of cancer of the breast. Lancet. 1971;298(7722):472–473. doi:10.1016/S0140-6736(71)92634-1.
   Google Scholar
• Gorbach SL. Estrogens, breast cancer, and intestinal flora. Rev Infect Dis. 1984;6(Suppl 1):S85–90. doi:10.1093/clinids/6.Supplement_1.S85.
   PubMedGoogle Scholar
• Awolade P, Cele N, Kerru N, Gummidi L, Oluwakemi E, Singh P. Therapeutic significance of β-glucuronidase activity and its inhibitors: A review. Eur J Med Chem. 2020;187:111921. doi:10.1016/j.ejmech.2019.111921.
   PubMed Web of Science ®Google Scholar
• Rosenberg L, Bethea TN, Viscidi E, Hong C-C, Troester MA, Bandera EV, Haiman CA, Kolonel LN, Olshan AF, Ambrosone CB, et al. Postmenopausal female hormone use and estrogen receptor–positive and –negative breast cancer in African American Women. J Natl Cancer Inst. 2016;108(4):djv361. doi:10.1093/jnci/djv361.
   PubMedGoogle Scholar
• Whitaker BL. Plasma β-glucuronidase levels in breast cancer. Br J Cancer. 1960;14(3):471–477. doi:10.1038/bjc.1960.51.
   PubMed Web of Science ®Google Scholar
• Beratis NG, Kaperonis A, Eliopoulou MI, Kourounis G, Tzingounis VA. Increased activity of lysosomal enzymes in the peritoneal fluid of patients with gynecologic cancers and pelvic inflammatory disease. J Cancer Res Clin Oncol. 2005;131(6):371–376. doi:10.1007/s00432-004-0649-5.
   PubMed Web of Science ®Google Scholar
• Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment. Cancers Basel. 2020;12(9):12. doi:10.3390/cancers12092465.
   Web of Science ®Google Scholar
• Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, et al. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome. 2018;6(1):136. doi:10.1186/s40168-018-0515-3.
   PubMed Web of Science ®Google Scholar
• He S, Li H, Yu Z, Zhang F, Liang S, Liu H, Chen H, Lü M. The gut microbiome and sex hormone-related diseases. Front Microbiol. 2021;12:711137. doi:10.3389/fmicb.2021.711137.
   PubMed Web of Science ®Google Scholar
• Beral V, Gaitskell K, Hermon C. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015;385:1835–1842.
   PubMed Web of Science ®Google Scholar
• Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, Alali Z, Bayik D, Lathia JD, Sangwan N, et al. Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer. Cancer Res. 2022;82(24):4654–4669. doi:10.1158/0008-5472.CAN-22-0455.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang Z, Cui L, Wen Y, Chen X, Gong F, Yi H. Opportunities and challenges of the human microbiome in ovarian cancer. Front Oncol. 2020;10:163. doi:10.3389/fonc.2020.00163.
   PubMed Web of Science ®Google Scholar
• Laschke MW, Menger MD. The gut microbiota: a puppet master in the pathogenesis of endometriosis? Am J Obstet Gynecol. 2016;215(1):.e68.1–.e68.4. doi:10.1016/j.ajog.2016.02.036.
   Web of Science ®Google Scholar
• Talwar C, Singh V, Kommagani R. The gut microbiota: a double-edged sword in endometriosis†. Biol Reprod. 2022;107:881–901. doi:10.1093/biolre/ioac147.
   PubMed Web of Science ®Google Scholar
• Qin R, Tian G, Liu J, Cao L. The gut microbiota and endometriosis: From pathogenesis to diagnosis and treatment. Front Cell Infect Microbiol. 2022;12:1069557. doi:10.3389/fcimb.2022.1069557.
   PubMed Web of Science ®Google Scholar
• Galvankar M, Singh N, Modi D. Estrogen is essential but not sufficient to induce endometriosis. J Biosci. 2017;42(2):251–263. doi:10.1007/s12038-017-9687-4.
   PubMed Web of Science ®Google Scholar
• Clemenza S, Vannuccini S, Ruotolo A, Capezzuoli T, Petraglia F. Advances in targeting estrogen synthesis and receptors in patients with endometriosis. Expert Opin Investig Drugs. 2022;31(11):1227–1238. doi:10.1080/13543784.2022.2152325.
   PubMedGoogle Scholar
• Jiang I, Yong PJ, Allaire C, Bedaiwy MA. Intricate connections between the microbiota and endometriosis. Int J Mol Sci. 2021;22(11):22. doi:10.3390/ijms22115644.
   Web of Science ®Google Scholar
• Brandelli A, Passos EP. Glycosidases in the peritoneal fluid from infertile women with and without endometriosis. Clin Biochem. 1998;31(3):181–186. doi:10.1016/S0009-9120(98)00012-5.
   PubMed Web of Science ®Google Scholar
• Graham ME, Herbert WG, Song SD, Raman HN, Zhu JE, Gonzalez PE, Walther-António MRS, Tetel MJ. Gut and vaginal microbiomes on steroids: implications for women’s health. Trends Endocrinol Metab. 2021;32(8):554–565. doi:10.1016/j.tem.2021.04.014.
   PubMed Web of Science ®Google Scholar
• Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Hum Reprod Update. 2007;13(6):559–565. doi:10.1093/humupd/dmm020.
   PubMed Web of Science ®Google Scholar
• Schreurs MPH, de Vos van Steenwijk PJ, Romano A, Dieleman S, Werner HMJ. How the gut microbiome links to menopause and obesity, with possible implications for endometrial cancer development. JCM. 2021;10(13):10. doi:10.3390/jcm10132916.
   Google Scholar
• Menon R, Watson SE, Thomas LN, Allred CD, Dabney A, Azcarate-Peril MA, Sturino JM. Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol. 2013;79(18):5763–5773. doi:10.1128/AEM.01182-13.
   PubMed Web of Science ®Google Scholar
• Meng Q, Ma M, Zhang W, Bi Y, Cheng P, Yu X, Fu Y, Chao Y, Ji T, Li J, et al. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites. Gut Microbes. 2021;13(1):1–27. doi:10.1080/19490976.2021.1880220.
   Web of Science ®Google Scholar
• Insenser M, Murri M, Del Campo R, Martínez-García MÁ, Fernández-Durán E, Escobar-Morreale HF. Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. J Clin Endocrinol Metab. 2018;103(7):2552–2562. doi:10.1210/jc.2017-02799.
   PubMed Web of Science ®Google Scholar
• Song CH, Kim N, Nam RH, Choi SI, Lee H-N, Surh Y-J. 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice. Sci Rep. 2020;10(1):12283. doi:10.1038/s41598-020-69112-w.
   PubMed Web of Science ®Google Scholar
• Tran A, Scholtes C, Songane M, Champagne C, Galarneau L, Levasseur M-P, Fodil N, Dufour CR, Giguère V, Saleh M, et al. Estrogen-related receptor alpha (ERRα) is a key regulator of intestinal homeostasis and protects against colitis. Sci Rep. 2021;11(1):15073. doi:10.1038/s41598-021-94499-5.
   PubMed Web of Science ®Google Scholar
• Mayneris-Perxachs J, Arnoriaga-Rodríguez M, Luque-Córdoba D, Priego-Capote F, Pérez-Brocal V, Moya A, Burokas A, Maldonado R, Fernández-Real J-M. Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status. Microbiome. 2020;8(1):136. doi:10.1186/s40168-020-00913-x.
   PubMed Web of Science ®Google Scholar
• de la Cuesta-Zuluaga J, Kelley ST, Chen Y, Escobar JS, Mueller NT, Ley RE, McDonald D, Huang S, Swafford AD, Knight R, et al. Age- and sex-dependent patterns of gut microbial diversity in human adults. mSystems. 2019;4(4):4. doi:10.1128/mSystems.00261-19.
   Web of Science ®Google Scholar
• Vaccaro CM, Capozzi A, Ettore G, Bernorio R, Cagnacci A, Gambacciani M, Coletta V, Maffei S, Nappi RE, Scambia G, et al. What women think about menopause: An Italian survey. Maturitas. 2021;147:47–52. doi:10.1016/j.maturitas.2021.03.007.
   PubMed Web of Science ®Google Scholar
• Mili N, Paschou SA, Armeni A, Georgopoulos N, Goulis DG, Lambrinoudaki I. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause. 2021;28(6):706–716. doi:10.1097/GME.0000000000001752.
   PubMed Web of Science ®Google Scholar
• Luo M, Li J, Tang R, Li HJ, Liu B, Peng Y, Wang Y, Liu G, Lin S, Chen R, et al. Insomnia symptoms in relation to menopause among middle-aged Chinese women: Findings from a longitudinal cohort study. Maturitas. 2020;141:1–8. doi:10.1016/j.maturitas.2020.06.010.
   PubMed Web of Science ®Google Scholar
• Zeng LN, Yang Y, Feng Y, Cui X, Wang R, Hall BJ, Ungvari GS, Chen L, Xiang Y-T. The prevalence of depression in menopausal women in China: A meta-analysis of observational studies. J Affect Disord. 2019;256:337–343. doi:10.1016/j.jad.2019.06.017.
   PubMed Web of Science ®Google Scholar
• Park S, Kim DS, Kang ES, Kim DB, Kang S. Low-dose brain estrogen prevents menopausal syndrome while maintaining the diversity of the gut microbiomes in estrogen-deficient rats. Am J Physiol Endocrinol Metab. 2018;315(1):E99–e109. doi:10.1152/ajpendo.00005.2018.
   PubMed Web of Science ®Google Scholar
• Guadamuro L, Delgado S, Redruello B, Flórez AB, Suárez A, Martínez-Camblor P, Mayo B. Equol status and changes in fecal microbiota in menopausal women receiving long-term treatment for menopause symptoms with a soy-isoflavone concentrate. Front Microbiol. 2015;6:777. doi:10.3389/fmicb.2015.00777.
   PubMed Web of Science ®Google Scholar
• Mörkl S, Butler MI, Lackner S. Advances in the gut microbiome and mood disorders. Curr Opin Psychiatry. 2022;36(1):1–7. doi:10.1097/YCO.0000000000000829.
   Web of Science ®Google Scholar
• Fang Y, Zhang J, Zhu S, He M, Ma S, Jia Q, Sun Q, Song L, Wang Y, Duan L, et al. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. Pharmacol Res. 2021;165:105439. doi:10.1016/j.phrs.2021.105439.
   PubMed Web of Science ®Google Scholar
• Sovijit WN, Sovijit WE, Pu S, Usuda K, Inoue R, Watanabe G, Yamaguchi H, Nagaoka K. Ovarian progesterone suppresses depression and anxiety-like behaviors by increasing the Lactobacillus population of gut microbiota in ovariectomized mice. Neurosci Res (NY). 2021;168:76–82. doi:10.1016/j.neures.2019.04.005.
   Google Scholar
• Huang J, Shan W, Li F, Wang Z, Cheng J, Lu F, Guo E, Beejadhursing R, Xiao R, Liu C, et al. Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice. Aging (Albany NY). 2021;13(5):7589–7607. doi:10.18632/aging.202627.
   PubMedGoogle Scholar
• Valko-Rokytovská M, Očenáš P, Salayová A, Kostecká Z. Breast cancer: Targeting of steroid hormones in cancerogenesis and diagnostics. Int J Mol Sci. 2021;22(11):22. doi:10.3390/ijms22115878.
   Web of Science ®Google Scholar
• Tan B, Zhang Y, Zhang T, He J, Luo X, Bian X, Wu J, Zou C, Wang Y, Fu L, et al. Identifying potential serum biomarkers of breast cancer through targeted free fatty acid profiles screening based on a GC–MS platform. Biomed Chromatogr. 2020;34(10):e4922. doi:10.1002/bmc.4922.
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271–285. doi:10.1038/nrc.2017.13.
   PubMed Web of Science ®Google Scholar
• Ofinran O, Bose U, Hay D, Abdul S, Tufatelli C, Khan R. Selection of suitable reference genes for gene expression studies in normal human ovarian tissues, borderline ovarian tumours and ovarian cancer. Mol Med Rep. 2016;14(6):5725–5731. doi:10.3892/mmr.2016.5933.
   PubMed Web of Science ®Google Scholar
• Jin Y, Tian X, Jin L, Cui Y, Liu T, Yu Z, Huo X, Cui J, Sun C, Wang C, et al. Highly specific near-infrared fluorescent probe for the real-time detection of β-glucuronidase in various living cells and animals. Anal Chem. 2018;90(5):3276–3283. doi:10.1021/acs.analchem.7b04813.
   PubMed Web of Science ®Google Scholar
• Li T, Li G, Su Z, Liu J, Wang P. Recent advances of sensing strategies for the detection of β-glucuronidase activity. Anal Bioanal Chem. 2022;414(9):2935–2951. doi:10.1007/s00216-022-03921-y.
   PubMed Web of Science ®Google Scholar
• Wang P, Jia Y, Wu R, Chen Z, Yan R. Human gut bacterial β-glucuronidase inhibition: An emerging approach to manage medication therapy. Biochem Pharmacol. 2021;190:114566. doi:10.1016/j.bcp.2021.114566.
   PubMed Web of Science ®Google Scholar
• Muccee F, Ghazanfar S, Ajmal W, Al-Zahrani M. In-silico characterization of estrogen reactivating β-glucuronidase enzyme in git associated microbiota of normal human and breast cancer patients. Genes (Basel). 2022;13(9):1545. doi:10.3390/genes13091545.
   PubMed Web of Science ®Google Scholar
• Walaszek Z, Szemraj J, Narog M, Adams AK, Kilgore J, Sherman U, Hanausek M. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev. 1997;21:178–190.
   PubMedGoogle Scholar
• Cheng KW, Tseng CH, Chen IJ, Huang B-C, Liu H-J, Ho K-W, Lin W-W, Chuang C-H, Huang M-Y, Leu Y-L, et al. Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis. Pharmacol Res. 2022;177:106115. doi:10.1016/j.phrs.2022.106115.
   PubMed Web of Science ®Google Scholar
• De Preter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K. Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr. 2008;62(2):225–231. doi:10.1038/sj.ejcn.1602706.
   PubMed Web of Science ®Google Scholar
• Letertre MPM, Bhatt AP, Harvey M, Nicholson JK, Wilson ID, Redinbo MR, Swann JR. Characterizing the metabolic effects of the selective inhibition of gut microbial β-glucuronidases in mice. Sci Rep. 2022;12(1):17435. doi:10.1038/s41598-022-21518-4.
   PubMed Web of Science ®Google Scholar
• Nishio S, Shimokawa M, Tasaki K, Nasu H, Yoshimitsu T, Matsukuma K, Terada A, Tsuda N, Kawano K, Ushijima K, et al. A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis. Gynecol Oncol. 2018;150(3):432–437. doi:10.1016/j.ygyno.2018.07.014.
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Pellock SJ, Biernat KA, Walton WG, Wallace BD, Creekmore BC, Letertre MM, Swann JR, Wilson ID, Roques JR, et al. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci USA. 2020;117(13):7374–7381. doi:10.1073/pnas.1918095117.
   PubMed Web of Science ®Google Scholar
• Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, Yokoi T, Kamataki T. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res. 1996;56:3752–3757.
   PubMed Web of Science ®Google Scholar
• Chamseddine AN, Ducreux M, Armand JP, Paoletti X, Satar T, Paci A, Mir O. Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacology & Therapeutics. 2019;199:1–15. doi:10.1016/j.pharmthera.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Wallace BD, Roberts AB, Pollet RM, Ingle J, Biernat K, Pellock S, Venkatesh M, Guthrie L, O’Neal S, Robinson S, et al. Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity. Chem Biol. 2015;22(9):1238–1249. doi:10.1016/j.chembiol.2015.08.005.
   PubMedGoogle Scholar
• Cheng KW, Tseng CH, Tzeng CC, Leu Y-L, Cheng T-C, Wang J-Y, Chang J-M, Lu Y-C, Cheng C-M, Chen I-J, et al. Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacol Res. 2019;139:41–49. doi:10.1016/j.phrs.2018.10.029.
   PubMed Web of Science ®Google Scholar
• Mego M, Chovanec J, Vochyanova-Andrezalova I, Konkolovsky P, Mikulova M, Reckova M, Miskovska V, Bystricky B, Beniak J, Medvecova L, et al. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complement Ther Med. 2015;23(3):356–362. doi:10.1016/j.ctim.2015.03.008.
   PubMed Web of Science ®Google Scholar
• Palko-Łabuz A, Maksymowicz J, Sobieszczańska B, Wikiera A, Skonieczna M, Wesołowska O, Środa-Pomianek K. Newly obtained apple pectin as an adjunct to irinotecan therapy of colorectal cancer reducing E. coli adherence and β-glucuronidase activity. Cancers Basel. 2021;13(12):2952. doi:10.3390/cancers13122952.
   PubMed Web of Science ®Google Scholar
• Pellock SJ, Creekmore BC, Walton WG, Mehta N, Biernat KA, Cesmat AP, Ariyarathna Y, Dunn ZD, Li B, Jin J, et al. Gut microbial β-glucuronidase inhibition via catalytic cycle interception. ACS Cent Sci. 2018;4(7):868–879. doi:10.1021/acscentsci.8b00239.
   PubMed Web of Science ®Google Scholar
• Little MS, Pellock SJ, Walton WG, Tripathy A, Redinbo MR. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Proc Natl Acad Sci USA. 2018;115(2):E152–e161. doi:10.1073/pnas.1716241115.
   PubMed Web of Science ®Google Scholar
• Wang P, Wu R, Jia Y, Tang P, Wei B, Zhang Q, Wang VYF, Yan R. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases. Int J Biol Macromol. 2022;220:1532–1544. doi:10.1016/j.ijbiomac.2022.09.018.
   PubMed Web of Science ®Google Scholar
• Sun CP, Yan JK, Yi J, Zhang X-Y, Yu Z-L, Huo X-K, Liang J-H, Ning J, Feng L, Wang C, et al. The study of inhibitory effect of natural flavonoids toward β-glucuronidase and interaction of flavonoids with β-glucuronidase. Int J Biol Macromol. 2020;143:349–358. doi:10.1016/j.ijbiomac.2019.12.057.
   PubMed Web of Science ®Google Scholar
• Bai Y, Chen L, Cao YF, Hou X-D, Jia S-N, Zhou Q, He Y-Q, Hou J. Beta-glucuronidase inhibition by constituents of Mulberry Bark. Planta Med. 2021;87(08):631–641. doi:10.1055/a-1402-6431.
   PubMed Web of Science ®Google Scholar
• Marlatt KL, Beyl RA, Redman LM. A qualitative assessment of health behaviors and experiences during menopause: A cross-sectional, observational study. Maturitas. 2018;116:36–42. doi:10.1016/j.maturitas.2018.07.014.
   PubMed Web of Science ®Google Scholar
• Chu K, Song Y, Chatooah ND, Weng Q, Ying Q, Ma L, Qu F, Zhou J. The use and discontinuation of hormone replacement therapy in women in South China. Climacteric. 2018;21(1):47–52. doi:10.1080/13697137.2017.1397622.
   PubMed Web of Science ®Google Scholar
• Seyed Hameed AS, Rawat PS, Meng X, Liu W. Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota. Biotechnol Adv. 2020;43:107576. doi:10.1016/j.biotechadv.2020.107576.
   PubMed Web of Science ®Google Scholar
• Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr. 2003;89(Suppl S1):S45–58. doi:10.1079/BJN2002796.
   PubMedGoogle Scholar
• Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, Heubi JE. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr. 2002;76(2):447–453. doi:10.1093/ajcn/76.2.447.
   PubMed Web of Science ®Google Scholar
• Mayo B, Vázquez L, Flórez AB. Equol: A bacterial metabolite from the daidzein isoflavone and its presumed beneficial health effects. Nutrients. 2019;11(9):11. doi:10.3390/nu11092231.
   Web of Science ®Google Scholar
• Liu C, He D, Yu A, Deng Y, Wang L, Song Z. Correlation analysis between gut microbiota characteristics and melasma. Front Microbiol. 2022;13:1051653. doi:10.3389/fmicb.2022.1051653.
   PubMed Web of Science ®Google Scholar
• Guadamuro L, Dohrmann AB, Tebbe CC, Mayo B, Delgado S. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones. BMC Microbiol. 2017;17(1):93. doi:10.1186/s12866-017-1001-y.
   PubMedGoogle Scholar
• Dai S, Pan M, El-Nezami HS, Wan JMF, Wang MF, Habimana O, Lee JCY, Louie JCY, Shah NP. Effects of lactic acid bacteria-fermented soymilk on isoflavone metabolites and short-chain fatty acids excretion and their modulating effects on gut microbiota. J Food Sci. 2019;84(7):1854–1863. doi:10.1111/1750-3841.14661.
   PubMed Web of Science ®Google Scholar
• Yuan L, Wagatsuma C, Yoshida M, Miura T, Mukoda T, Fujii H, Sun B, Kim J-H, Surh Y-J. Inhibition of human breast cancer growth by GCP™ (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of genistein biotransformation by β-glucuronidase from tumor tissues. Mutat Res. 2003;523-524:55–62. doi:10.1016/S0027-5107(02)00321-4.
   PubMed Web of Science ®Google Scholar
• Sawane K, Nagatake T, Hosomi K, Kunisawa J. Anti-allergic property of dietary phytoestrogen secoisolariciresinol diglucoside through microbial and β-glucuronidase-mediated metabolism. J Nutr Biochem. 2023;112:109219. doi:10.1016/j.jnutbio.2022.109219.
   PubMed Web of Science ®Google Scholar
• Łaniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020;17(4):232–250. doi:10.1038/s41585-020-0286-z.
   PubMed Web of Science ®Google Scholar
• Lim EY, Song EJ, Kim JG, Jung SY, Lee S-Y, Shin HS, Nam Y-D, Kim YT. Lactobacillus intestinalis YT2 restores the gut microbiota and improves menopausal symptoms in ovariectomized rats. Benef Microbes. 2021;12(5):503–516. doi:10.3920/BM2020.0217.
   PubMed Web of Science ®Google Scholar
• Farvid MS, Spence ND, Holmes MD, Barnett JB. Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies. Cancer. 2020;126(13):3061–3075. doi:10.1002/cncr.32816.
   PubMed Web of Science ®Google Scholar
• Zengul AG, Demark-Wahnefried W, Barnes S, Morrow CD, Bertrand B, Berryhill TF, Frugé AD. Associations between dietary fiber, the fecal microbiota and estrogen metabolism in postmenopausal women with breast cancer. Nutr Cancer. 2021;73(7):1108–1117. doi:10.1080/01635581.2020.1784444.
   PubMed Web of Science ®Google Scholar
• Arts CJ, de Bie AT, van den Berg H, van ’t Veer P, Bunnik GSJ, Thijssen JHH. Influence of wheat bran on NMU-induced mammary tumor development, plasma estrogen levels and estrogen excretion in female rats. J Steroid Biochem Molecular Biol. 1991;39(2):193–202. doi:10.1016/0960-0760(91)90063-B.
   PubMed Web of Science ®Google Scholar
• Jeong SY, Kang S, Hua CS, Ting Z, Park S. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats. Genes Nutr. 2017;12(1):31. doi:10.1186/s12263-017-0585-z.
   PubMedGoogle Scholar
• Wu X, Kim MJ, Yang HJ, Park S. Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats. Eur J Nutr. 2021;60(4):1907–1919. doi:10.1007/s00394-020-02382-2.
   PubMed Web of Science ®Google Scholar
• Lønning PE, Haynes BP, Straume AH, Dunbier A, Helle H, Knappskog S, Dowsett M. Exploring breast cancer estrogen disposition: the basis for endocrine manipulation. Clin Cancer Res. 2011;17(15):4948–4958. doi:10.1158/1078-0432.CCR-11-0043.
   PubMed Web of Science ®Google Scholar
• Challa AP, Hu X, Zhang YQ, Hymes J, Wallace BD, Karavadhi S, Sun H, Patnaik S, Hall MD, Shen M, et al. Virtual screening for the discovery of microbiome β-glucuronidase inhibitors to alleviate cancer drug toxicity. J Chem Inf Model. 2022;62(7):1783–1793. doi:10.1021/acs.jcim.1c01414.
   PubMed Web of Science ®Google Scholar